Electroretinogram

Global Electroretinogram Market to Reach US$2.1 Billion by 2030

The global market for Electroretinogram estimated at US$1.4 Billion in the year 2024, is expected to reach US$2.1 Billion by 2030, growing at a CAGR of 7.4% over the analysis period 2024-2030. Full-field flash ERG, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$1.3 Billion by the end of the analysis period. Growth in the Pattern ERG segment is estimated at 5.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$368.1 Million While China is Forecast to Grow at 11.7% CAGR

The Electroretinogram market in the U.S. is estimated at US$368.1 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$441.8 Million by the year 2030 trailing a CAGR of 11.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.6% and 7.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.9% CAGR.

Global Electroretinogram Market – Key Trends & Drivers Summarized

What Is an Electroretinogram, and Why Is It Essential in Ophthalmology?

An electroretinogram (ERG) is a diagnostic test used to measure the electrical response of the retina to light stimulation, providing critical insights into the functional status of the retinal cells, particularly the photoreceptors and inner retinal layers. This non-invasive procedure is widely used in diagnosing a range of retinal disorders, including retinitis pigmentosa, cone-rod dystrophy, Leber’s congenital amaurosis, and diabetic retinopathy. With the rising prevalence of retinal diseases due to aging populations, diabetes, and genetic conditions, ERG testing has become increasingly significant in both clinical and research settings. Technological advancements have led to the development of multifocal ERG (mfERG) and pattern ERG (pERG), which offer higher precision and better localization of retinal dysfunction. Additionally, portable and handheld ERG devices are gaining traction due to their convenience in point-of-care settings. The growing integration of artificial intelligence (AI) in retinal diagnostics has also enhanced the interpretation of ERG results, enabling faster and more accurate detection of early-stage retinal disorders. As the field of ophthalmology continues to embrace precision medicine, ERG testing is expected to play a more pivotal role in personalized treatment planning and monitoring disease progression.

How Are Technological Innovations Transforming the Electroretinogram Market?

The electroretinogram market has witnessed significant technological progress in recent years, particularly in terms of device miniaturization, improved electrode designs, and software-driven analytical tools. Traditional ERG systems required extensive setup and calibration, but modern advancements have led to the development of wireless and non-invasive electrodes that enhance patient comfort and test accuracy. The adoption of photopic negative response (PhNR) ERG has expanded applications beyond conventional retinal diagnostics to include early detection of glaucoma and optic nerve diseases. Another breakthrough in ERG technology is the integration of cloud-based platforms that enable remote analysis of ERG data, facilitating telemedicine solutions for retinal care. Furthermore, advancements in signal processing algorithms have significantly reduced noise artifacts, improving the reliability of ERG readings in clinical and research applications. Researchers are also exploring the potential of artificial intelligence (AI) and machine learning (ML) to automate ERG analysis, further accelerating diagnostic efficiency. With the continued evolution of electrophysiology techniques, the next generation of ERG devices is expected to offer even greater precision, speed, and accessibility, broadening their application in various medical specialties.

Which Factors Are Driving the Growing Demand for Electroretinography?

The increasing prevalence of retinal and neuro-ophthalmic disorders is the primary driver of demand for electroretinography. With the global rise in diabetes cases, diabetic retinopathy has emerged as a leading cause of blindness, necessitating early and accurate diagnosis through ERG testing. Similarly, age-related macular degeneration (AMD) and inherited retinal dystrophies are becoming more prevalent, further driving the adoption of ERG in ophthalmology clinics and research institutions. Pediatric ophthalmology has also benefited from advancements in ERG technology, as early detection of congenital retinal disorders can improve clinical outcomes through timely interventions. Beyond ophthalmology, ERG is increasingly used in neurological studies, particularly for evaluating retinal biomarkers in neurodegenerative diseases such as Parkinson’s and Alzheimer’s. The growing availability of portable ERG systems has expanded its adoption in point-of-care diagnostics, allowing for efficient screening in non-hospital settings. Moreover, pharmaceutical and biotechnology companies are leveraging ERG testing in clinical trials to assess the retinal safety profiles of new drug candidates, reinforcing the importance of ERG in drug development and regulatory approvals.

What Is Driving the Growth of the Electroretinogram Market?

The growth in the electroretinogram market is driven by several factors, including advancements in diagnostic imaging technologies, increasing investment in ophthalmic research, and the rising demand for early disease detection solutions. The development of handheld and portable ERG devices has significantly increased accessibility, particularly in emerging markets where healthcare infrastructure is still developing. The integration of AI-driven analytics in ERG interpretation has also improved diagnostic precision, reducing the dependence on specialized electrophysiologists. Additionally, the expansion of teleophthalmology services has driven the need for remote diagnostic solutions, making ERG devices more relevant in modern healthcare settings. The pharmaceutical industry’s growing reliance on ERG for ophthalmic drug safety testing has further accelerated market growth, as regulatory agencies increasingly require comprehensive visual function assessments in clinical trials. Moreover, government initiatives focused on preventing blindness and improving eye health, particularly in aging populations, have led to increased funding for ophthalmic diagnostic devices, including ERG systems. As the field of personalized medicine advances, ERG is expected to play a critical role in tailoring treatment strategies for retinal diseases, positioning it as a key growth area in the broader ophthalmic diagnostics market.

SCOPE OF STUDY:

The report analyzes the Electroretinogram market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Type (Full-field flash ERG, Pattern ERG, Multifocal ERG); Product (Handheld, Tabletop); Application (Clinical Diagnostic, Research)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

• Allison Medical
• Bio-Rad Laboratories
• Cadwell Industries, Inc.
• ChongQing SunKingdom Medical Instrument
• CSO Italia
• Diagnosys LLC
• Diopsys, Inc.
• Electro-Diagnostic Imaging, Inc.
• Fabrinal
• Haag-Streit Group
• HEINE Optotechnik
• Konan Medical USA, Inc.
• LKC Technologies, Inc.
• Marco Ophthalmic
• Metrovision
• M&S Technologies
• Neurosoft
• NIDEK Co., Ltd.
• Ocular Instruments
• Opto-Medic Co Pte Ltd

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.